Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-01-28

Clinical Trial Update: Adalimumab in the Treatment of Chronic Pouchitis [Phase 3]

View source ↗

Summary

Phase 3 trial update shows completion of a study evaluating adalimumab for chronic pouchitis in patients with ulcerative colitis. The snippet lists the status a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: Odense University Hospital | Conditions: Ulcerative Colitis, Pouchitis | Phase 3 | Status: COMPLETED